Intech was established in 2010 as a spin off from parent company Synmosa. Building on the fundamentals in inhalation products from Synmosa Intech has becomea successful player in the field respiratory drug development and now the company is expanding to global markets…... more


Intech is focusing on the development and manufacturing of new drug combinations, new formulations and generic drugs with high entry barriers in the field of respirator treatments. Using its unique technology, it is moving forward to international market…... more


Intech owns the patented MDI platform iLEF (Inhaled Low Ethanol Formulation ) which has many advantages. The particle size of drug ingredients is well controlled and delivered to the suitable tissue of human body to treat asthma and COPD…... more